These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23783552)

  • 1. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
    Dai Z; Jin Y
    Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
    Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
    Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
    J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
    Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
    Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
    Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
    J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
    Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
    Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.
    Zhang Q; Ying J; Zhang K; Li H; Ng KM; Zhao Y; He Q; Yang X; Xin D; Liao SK; Tao Q; Jin J
    Cancer Lett; 2007 May; 249(2):220-6. PubMed ID: 17029774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line.
    Jin Y; Tian X; Shang Y; Huang P
    Oncol Rep; 2008 Mar; 19(3):669-74. PubMed ID: 18288400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of MTUS1 in human colon tumors.
    Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S
    Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
    Liu Y; Zhou J; Hu Y; Wang J; Yuan C
    Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.